Clinical Trials Logo
  1. Home
  2. Bone Marrow Transplant Infection
  3. NCT02804464

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time) — DISCOVER  

Bone Marrow Transplant Infection Clinical Trial

Official title:
The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

Clinical Trial Summary

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02804464
Study type Observational
Source Karius, Inc.
Contact
Status Active, not recruiting
Phase
Start date July 2016
Completion date July 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04687982 - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). N/A
Completed NCT02263703 - Immunogenicity of HPV Vaccine in Immunosuppressed Children Phase 3
Recruiting NCT05471661 - T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation Phase 1/Phase 2
Completed NCT02032381 - Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells. N/A
Not yet recruiting NCT04709848 - Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
Completed NCT04892160 - Distracting Through Procedural Pain and Distress N/A
Active, not recruiting NCT03180216 - T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation Phase 1
Completed NCT01502072 - Respiratory Syncytial Virus - RSV Protocol Phase 2